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Amenorrhea during antipsychotics treatment
In full remission psychotic patient the resolution of hyperprolactinemia has attracted the most attention. Aripiprazole can be used to resolve hyperprolactinemia induced by risperidone 8 , amisulpride, and ziprasidone 9 . However, the use of aripiprazole to resolve MARTA-induced amenorrhea has rarely been reported, especially in amenorrhea without hyperprolactinemia. Some may believe that since aripiprazole can reduce amenorrhea, we should attempt to use it in the early stages of disease onset in women.
It should be noted that in Case 2, aripiprazole was used during the early stages of disease onset. However, due to its slow antimanic effect, it was combined with zotepine after four weeks, and was only completely replaced by zotepine (100 mg/d) after eight weeks, followed by a switch to aripiprazole after the unexpected occurrence of amenorrhea. In both cases, full D2 antagonists were used initially for rapid therapeutic effect until full remission of the mental disorder, and then were successfully replaced by aripiprazole completely over one to two months. This was a viable therapeutic strategy. Above is the past discharge medication list.
In conclusion, when using antipsychotics among premenopausal women, we should consider the possibility of self-discontinuation of medications due to amenorrhea. Hence, after achieving rapid symptom alleviation using non-aripiprazole antipsychotics, the patient should be switched to aripiprazole, which prevents amenorrhea and may also achieve weight loss. Further clinical studies are needed to explore possible solutions to amenorrhea induced by antipsychotics. Figure 1 summarizes the clinical algorithm used when patients are suspected of antipsychotic-induced amenorrhea 7 .
